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Abstract
Growth plate chondrocytes progress through a proliferative phase before acquiring a terminally-differentiated phenotype.
In this study we used Percoll density gradients to separate chick growth plate chondrocytes into populations of different
maturational phenotype. By applying agarose gel differential display to these populations we cloned a cDNA encoding a
novel 268 amino acid protein (3X11A). 3X11A contains two peptide motifs that are conserved in a recently identified
superfamily of phosphotransferases. It is likely that 3X11A is a phosphatase, but its substrate specificity remains uncertain.
3X11A expression is upregulated 5-fold during chondrocyte terminal differentiation and its expression is approximately 100-
fold higher in hypertrophic chondrocytes than in non-chondrogenic tissues. This suggests that 3X11A participates in a
biochemical pathway that is particularly active in differentiating chondrocytes. ß 1999 Elsevier Science B.V. All rights
reserved.
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In higher vertebrates, longitudinal bone growth
occurs at the epiphyseal growth plate. The process
is termed endochondral ossi¢cation and is of funda-
mental importance in the growth and development of
the appendicular skeleton. The sequence of cellular
transitions that occurs within the growth plate have
been characterised by a combination of morpholog-
ical, ultrastructural and biochemical studies [1].
Brie£y, chondrocytes emerge from a reserve zone at
the epiphyseal edge of the growth plate and progress
through a proliferative phase during which they have
a characteristic £attened morphology. After a num-
ber of cell divisions, proliferation ceases and the cells
hypertrophy and gradually acquire a terminally dif-
ferentiated phenotype. Di¡erentiation is accompa-
nied by increases in the expression of type X colla-
gen, alkaline phosphatase (ALP) and other speci¢c
macromolecules [2^4]. Acquisition of the hypertro-
phic phenotype by growth plate chondrocytes ap-
pears to be essential for subsequent vascular invasion
and replacement of the matrix by bone [5,6]. Conse-
quently, the transition between proliferation and hy-
pertrophy is a critical step during endochondral os-
si¢cation. We wish to characterise the proliferative
and hypertrophic phenotypes more fully and in par-
ticular to identify factors that may regulate chondro-
cyte di¡erentiation and/or matrix resorption. To this
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end we have explored the use of Percoll density frac-
tionation [7,8] as a method for separating chick
growth plate chondrocytes into di¡erent phenotypic
populations. By combining Percoll fractionation with
agarose gel di¡erential display we have identi¢ed a
novel phosphatase that is highly expressed by di¡er-
entiating chondrocytes.
Chondrocytes were isolated from growth plates of
proximal tibiotarsi of 3-week-old chicks by collagen-
ase digestion as described previously [9]. Discontin-
uous Percoll gradients were made up in Corning pol-
ystyrene culture tubes (16U125 mm) and consisted
of 2 ml of each of 6 density solutions, 1.04^1.09 g/ml,
prepared in 0.15 M NaCl. 1 ml aliquots containing
40^50U106 chondrocytes were layered onto each
gradient and centrifuged for 30 min at 400Ug at
25‡C. The Percoll fractionated chondrocytes (PFCs)
were harvested by aspiration, washed in 20 ml 0.15 M
NaCl, and resuspended in 1 ml of this solution.
Samples were taken at this stage to assess cell num-
ber, size, viability and ALP activity. In some cases
birds were injected with bromodeoxyuridine (BrdU)
1 h before death and cytospin preparations of cells
obtained by Percoll fractionation were stained by
immuno£uorescence to detect proliferating cells
[10]. The remaining cells were re-pelleted and stored
at 370‡C prior to RNA extraction. The mean cell
volume of each Percoll fraction was measured on a
Macintosh computer using the public domain soft-
ware package NIH-Image 1.60. Alkaline phosphatase
activity in cells from each fraction was measured as
described previously [9].
For total RNA extraction the cell pellets were ho-
mogenised in 1.5 ml Ultraspec (Biotecx) by repeated
passage through a 25 gauge syringe needle. After
extraction with chloroform, RNA in the aqueous
phase was precipitated with isopropanol and bound
to RNA Tack Resin (Biotecx), following the manu-
facturers protocol. The RNA was ¢nally eluted in
100 Wl RNase-free H2O. To extract total RNA
from tissue samples 0.5^1.0 g of tissue was homoge-
nised in 10 volumes of Ultraspec using an Ultraturax
homogeniser and total RNA puri¢ed as above. Agar-
ose gel di¡erential display was performed as de-
scribed by Je¡eries et al. [11] in 20 Wl reactions con-
taining the equivalent of 50 ng RNA. The cycling
pro¢le used was: 30 s at 94‡C (1st cycle 2 min);
1 min at 40‡C; 1 min at 72‡C for 40 cycles followed
by 10 min at 72‡C. The primers used to identify the
gene we refer to as 3X11A were: DD3;
GTGGAAGCGT and DD11; CACAGTGAGC.
They were used at a concentration of 2 WM. Reaction
products were resolved on 3% NuSieve 3:1 agarose
gels (Flowgen) run in the presence of ethidium bro-
mide (250 Wg/l). Bands of interest were excised from
the gels and cloned directly into the T-vector PCRII-
Topo (InVitrogen). For sequence analysis plasmid
minipreps were prepared (Qiagen) and sequenced
on a LICOR 4200 automated sequencer (MWG-Bio-
tech). Sequence database searches were conducted
using FASTA and BLAST programs via the EBI
World Wide Web server (URL: http://www.ebi.
ac.uk).
The expression of speci¢c genes was analysed by
semi-quantitative RT-PCR. 500 ng RNA was reverse
transcribed using the Superscript II preampli¢cation
system (BRL Life Technologies). All PCRs were per-
formed in 20 Wl reactions containing cDNA equiva-
lent to 10 ng RNA, TLA bu¡er [12], 0.2 U Taqstart
antibody (Clontech), 2 U Taq DNA polymerase and
gene-speci¢c oligonucleotide primers at 200 nM. All
genes were assayed using the cycling pro¢le: 1 min at
92‡C (1st cycle 2 min); 1 min at 55‡C; 1 min at 70‡C.
The number of cycles varied between genes and were
chosen to ensure that band intensity was proportion-
al to the amount of target. The primers and the
number of cycles (in parentheses) used for each
gene were L-actin, TGTGGTATCCATGAAACTA
and ATTCATCGTACTCCTGCCT (25); type II
collagen, GCAGAGACCATCAACGGCGGT and
CAGGAGCGAGGTCTTCTGCGA (17); type X
collagen, GGAGAGTCTAGAGAACTATCAGG and
ATTCTGAATTCGGCAGCTGGAGC (19); extra-
cellular fatty acid binding protein (Ex-FABP), GA-
CTTCTTCCTGCGTGAGAAGG and ATCAACG-
CTGCATTCCTCCTGG (25); 3X11A, GCATTGA-
GTGCAAACTGAGG and GCTGCTTCTTC-
TCCATCTCC (25 or 29). Oligonucleotide primers
for 18S RNA were obtained from Ambion and re-
quired 14 cycles. 10 Wl of each reaction were analysed
on 1.5% agarose gels run in the presence of ethidium
bromide (250 Wg/l). The banding pattern on each gel
was captured using a Bio-Rad Gel Doc image anal-
ysis system and PCR products were quanti¢ed by
measuring signal intensity using NIH Image soft-
ware.
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Fig. 1. Analysis of cell volume, ALP activity and marker gene expression in Percoll fractionated growth plate chondrocytes. In the
gene expression studies each graph shows the mean þ S.E.M. of the signal intensity measured in cells from three independent Percoll
gradients, while the inset shows a typical banding pattern. Units for ALP activity are nmol pNPP hydrolysed per min. Signal inten-
sities are in arbitrary units.
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After Percoll fractionation (Fig. 1), fraction 1 con-
tained the largest cells and fraction 5 the smallest in
keeping with the results of other workers who have
shown that the chondrocyte volume is inversely pro-
portional to their buoyant density [7]. Alkaline phos-
phatase activity, which is a marker of chondrocyte
hypertrophy [2], was highest in fraction 1 and de-
creased progressively in successive fractions. The ex-
pression of the hypertrophic markers Ex-FABP [13]
and type X collagen was highest in the cells of frac-
tion 1 and decreased dramatically in successive frac-
tions, so that their expression was virtually undetect-
able in fractions 4 and 5. We estimate from the signal
intensities that the expression of Ex-FABP and type
X collagen decreased 92- and 130-fold between frac-
tions 1 and 5. In contrast, the PFCs expressed type II
collagen at a constant level, in keeping with its uni-
form distribution in the growth plate [2]. A propor-
tion of the cells in fractions 3, 4 and 5 stained pos-
itively for BrdU with those of fraction 4 containing,
by far, the highest percentage of labelled cells. No
BrdU-labelled cells were found in fractions 1 and 2
(results not shown). These results indicate that frac-
tions 1 and 2 contain predominantly terminally dif-
ferentiated, hypertrophic cells and that proliferating
chondrocytes are found in fractions 4 and 5. Frac-
tion 3 is likely to contain a mixture of both cell
types.
To identify genes that were di¡erentially expressed
within the growth plate we performed (in triplicate) a
di¡erential display analysis on RNA extracted from
PFCs using 26 combinations of the 10-mer primers
given in [14]. Using this approach we identi¢ed and
cloned a 979 bp band which we named 3X11A (from
the primer pair used in that experiment) that was
derived from a transcript more abundantly expressed
in fractions 1 and 2. Analysis of the DNA sequence
of this clone indicated that it contained a potential
open reading frame encoding a 268 amino acid pro-
tein with an Mr of 30442 and a pI of 6.81 (Fig. 2).
Comparison of the 3X11A amino acid sequence with
entries in protein sequence databases using the
BLAST algorithm revealed similarity to phosphoser-
ine phosphatase (PSP), the enzyme that catalyses the
¢nal step in the biosynthesis of serine from glycolytic
precursors. An alignment of the amino acid sequence
of the 3X11A protein with PSPs from 5 prokaryotic
and 4 eukaryotic species (Fig. 3A) showed, however,
that 3X11A had only 14^18% overall identity to
PSPs suggesting that 3X11A is not the chick homo-
log of PSP. It was apparent from the alignment that
the conserved residues were not distributed uni-
Fig. 2. Nucleotide sequence of 3X11A and its deduced amino acid sequence. An N-terminal pentapeptide corresponding to a motif
that is conserved in the active site of a superfamily of phosphotransferases is underlined. A C-terminal, hexapeptide corresponding to
a second active site motif also conserved in these enzymes is double underlined.
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Fig. 3. Comparison of 3X11A with related proteins. Sequences were aligned using the DNASTAR program MEGALIGN. (A) Align-
ment of the 3X11A sequence with those of phosphoserine phosphatases from the species indicated. Shading indicates where a residue
is conserved between 3X11A and at least one phosphoserine phosphatase. (B) Alignment of the sequence around the conserved motifs
in 3X11A with the corresponding regions in other members of the phosphotransferase superfamily. Shading indicates where a residue
is conserved between 3X11A and at least one other enzyme. Motif 2 is not present in L-phosphoglucomutase, deoxyglucose 6-P phos-
phatase or glycerol 3-P phosphatase.
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formly throughout the sequence but were clustered
around two amino acid motifs, DFDGT, residues
32^36 (motif 1) and GDGAND, residues 202^207
(motif 2) (Fig. 3A). By performing a second database
search using only these motifs we identi¢ed a number
of other proteins that are members of a recently
identi¢ed superfamily of enzymes catalysing phos-
photransferase reactions [15,16]. This superfamily in-
cludes the P-type ATPases, a large class of enzymes
that use the free energy of the hydrolysis of ATP to
transport cations across cell membranes; a number
of phosphatases that catalyse the generation of inor-
ganic phosphate from a variety of phosphomonoest-
er substrates and two phosphomutases that catalyse
the transfer of a phosphoryl group between adjacent
carbon atoms of hexose monophosphates [15,16].
The reactions catalysed by the members of this
superfamily appear to proceed through a similar
mechanism. Consequently, the active sites of these
enzymes share structural features and this is re£ected
in the conservation of certain active site residues cor-
responding to the two motifs identi¢ed above. Fig.
3B shows an alignment of the sequence around the
conserved motifs in 3X11A, with the equivalent re-
gions from representative members of each class of
enzyme in the superfamily. With the exception of
phosphoserine phosphatase, 3X11A has no similarity
outwith these motifs. The ¢rst aspartate in the
DFDGT motif is totally conserved in all members
of this superfamily and is transiently phosphorylated
during the reaction. The DFDGT motif of 3X11A
matches the consensus motif DFDXT that is con-
served in the phosphatases and phosphomutases in
this superfamily (Fig. 3, [16]) and is distinct from the
totally conserved DKTGT motif of the P-type AT-
Pases. Together with the absence of transmembrane
domains in its sequence, this indicates that 3X11A is
not a P-type ATPase. The second motif is less well
conserved in this superfamily (Fig. 3A). However, we
consider that 3X11A is likely to be a phosphatase
rather than a phosphomutase since the structure of
its GDGAND motif more closely matches that of the
phosphatases and P-type ATPases (GDX[NT]D)
rather than that of the phosphomutases. The reac-
tion catalysed by 3X11A remains unknown.
To con¢rm that 3X11A is indeed di¡erentially ex-
pressed in the growth plate we designed speci¢c oli-
gonucleotide primers and used these in semi-quanti-
tative RT-PCR assays for 3X11A expression in PFCs
(Fig. 4A). A single band of the predicted size (336
bp) was detected. The signal intensity was constant
in fractions 1^3 and decreased progressively in frac-
Fig. 4. Pattern of expression of 3X11A. (A) 3X11A expression in growth plate chondrocytes. The graph shows the mean signal inten-
sity ( þ S.E.M.) measured in RNA puri¢ed from cells obtained from 3 independent density gradients. The signal intensity is in arbi-
trary units. The inset shows the banding pattern from a typical gel. (B) Distribution and abundance of 3X11A in chick tissues.
3X11A expression was measured by RT-PCR using speci¢cally designed primers in RNA puri¢ed from the tissues indicated.
BBAMCR 10395 6-1-99
B. Houston et al. / Biochimica et Biophysica Acta 1448 (1999) 500^506 505
tions 4 and 5. These results therefore con¢rm those
of the di¡erential display analysis, and based on the
di¡erence in intensity of the bands in fractions 1 and
5 we estimate that the expression of 3X11A is up-
regulated 5-fold during chondrocyte di¡erentiation.
To determine the tissue distribution of 3X11A tran-
scripts, similar assays were performed on RNA ex-
tracted from various tissues. By increasing the cycle
number to 29, 3X11A expression was detected at a
uniform level in cardiac muscle, liver, lung, kidney,
brain, spleen, skeletal muscle and adipose tissue (Fig.
4B). However, 3X11A expression was markedly ele-
vated in terminally di¡erentiated growth plate chon-
drocytes compared to all other tissues assayed. From
the band intensities we estimate that 3X11A expres-
sion in these cells was some 100-fold higher than in
the non-chondrogenic tissues. This pattern of expres-
sion would seem to indicate that 3X11A participates
in a biochemical pathway that is particularly active
in di¡erentiating chondrocytes. Since 3X11A appears
to be a phosphatase, we speculate that it may be
involved the generation of inorganic phosphate dur-
ing matrix mineralisation. This role is generally at-
tributed to ALP but this enzyme can be removed
from some preparations of matrix vesicles without
impairing their ability to mineralise [17]. Addition-
ally, a number of studies have shown that in addition
to ALP, growth plate chondrocytes express several
distinct phosphatases and ATPases that are involved
in mineralisation [18,19], although the speci¢c endog-
enous substrates have not yet been identi¢ed. Fur-
ther progress in understanding the role of 3X11A in
chondrocyte biochemistry must await the identi¢ca-
tion of the reaction catalysed by this enzyme.
This work was funded by the Biotechnology and
Biological Sciences Research Council, the Ministry
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